ResearchSafe

IDRA‑21: New AMPA PAM Shakes Up Memory Trial – Thoughts

Posted by greg208 in Research & News - 6 points, 4 comments.

org/peptides/idra-21) that shows a single oral dose of 20 mg in mice improves memory consolidation and learning speed for 48‑72 hours. They used a standard Morris water maze and reported a 30 % improvement in escape latency after the first dose, with effects persisting even after the drug is gone. For me the idea of an AMPA PAM that stays in the brain for a vurdering of a couple of days is exciting – it feels like a middle ground between nootropics that wear off quickly and more permanent neural changesextensions.

The authors note the theoretical risk of excitotoxicity and keep the dose low, but I worry about the headache reports they mention and the fact that the safety window in rodents might not translate cleanly to humans. I’ve had a few days where a low dose of an AMPA modulator seemed to help focus, but the headaches turned my coffee to a brew of headaches. Are you all seeing any real cognitive lift with AMPA PAMs, or is it just a placebo buzz?

Comments

  • sleep_coastal: I’ve dabbled with a few AMPA PAMs in the past, mainly CX‑717 on very low doses. Anecdotally the focus pop was real, but the headaches followed like a bad coffee that never really settled. I didn’t see the 30 % maze jump the miceambi showed, just a vague “I can stay on a task longer”. The brain’s excitability balance is tight; what’s safe in mice can feel like a migraine in humans. I’m still watching for any long‑term changes, but I’d ask, did anyone notice a sustained memory boost beyond the fi
  • tracker_skeptical: Fwiw I tried a single 20 mg dose of IDRA‑21 last month. The focus bump was noticeable for about a day then tapered off; I didn’t feel any extra memory boost on day two. Just my own experience.
  • greg208: Great to hear from you – not gonna lie I was hoping the focus bump would linger a bit longer, but a day’s lift aligns with what the paper suggests about the pharmacokinetics. Did you notice any headache flare‑ups after the first dose? I had a mild one after my 20 mg, so wondering if it’s a dose limit orJF issue. Would love to hear if you tried any staggered dosing or took the drug with food to see if it tweaks the duration.
  • greg208: I haven’t trialled IDRA‑21 yet – just the mice data and a quick 5 mg CX‑717 run. The focus lasted maybe a couple of hours, but by the next day my recall was back to baseline. Anyone who noticed a memory lift past 24 h? How long did you stay on the same task before the effect faded? I’ll try IDRA‑21 next week and give you an update.

Community discussion - research and educational context only. Not medical advice.